Greenwood Capital Associates LLC Merck & Co., Inc. Transaction History
Greenwood Capital Associates LLC
- $755 Million
- Q3 2024
A detailed history of Greenwood Capital Associates LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 1,926 shares of MRK stock, worth $199,899. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,926
Previous 14,231
86.47%
Holding current value
$199,899
Previous $1.76 Million
87.62%
% of portfolio
0.03%
Previous 0.24%
Shares
22 transactions
Others Institutions Holding MRK
# of Institutions
3,805Shares Held
1.92BCall Options Held
13.4MPut Options Held
10.6M-
Vanguard Group Inc Valley Forge, PA245MShares$25.4 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$21.5 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$12.2 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.52 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$5.92 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $263B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...